Aim & Scope
The term "Oncotarget" encompasses all molecules, pathways, and cellular processes common in cancer and aging, which include neurodegeneration, atherosclerosis, lymphocytes, neurons, cancer cells and microbes. Publication of outstanding research. Oncotarget publishes research papers in cancer research and oncology (primary focus). Due to the complexity of tumor development and integrity of the human organism, Oncotarget also publishes papers in the fields of endocrinology, pathology, age-related diseases, physiology, and immunology. Oncotarget beyond oncology: Sections with Advisory/Editorial boards on: Gerotarget (Aging), Pathology (all disciplines besides oncology), Chromosome, Immunology, Autophagy and Cell Diseases. Coming soon: Stem Cell and Neuroscience. [1]
2024 - VOLUME 15
From osimertinib to preemptive combinations.
Oncotarget , 2024 - VOLUME 15 , pp 232-237.
0
32
Editorial Retractions, Expressions of Concern and External Notices
T Kashyap , C Argueta , T Unger , ... , Y Landesman
Oncotarget2018 - VOLUME 9, ISSUE 56 pp 30773-30786.
35 50
K Husain , BA Centeno , D Coppola , ... , MP Malafa
Oncotarget2017 - VOLUME 8, ISSUE 19 pp 31554-31567.
23 44
A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.
B Neveu , P Jain , B Têtu , ... , F Pouliot
Oncotarget2016 - VOLUME 7, ISSUE 2 pp 1300-1310.
15 31
AR-v7 protein expression is regulated by protein kinase and phosphatase.
Y Li , N Xie , ME Gleave , ... , X Dong
Oncotarget2015 - VOLUME 6, ISSUE 32 pp 33743-33754.
30 32
CC Yang , L Fazli , S Loguercio , ... , DA Wolf
Oncotarget2015 - VOLUME 6, ISSUE 26 pp 22060-22071.
7 40